As shown in Figure 4, TAO, brain AChE, and serum AChE levels were significantly (p < 0.001) elevated in the AD-induced groups to 1.64 ± 0.09 mmol Equiv/l, 56.41 ± 5.21 U/mL, and 70.42 ± 6.83 U/mL, respectively, compared to the NC group. This evidence concerns the gene ACHE and Alzheimer disease.